MeVis Medical Solutions AG (M3V.DE)
EUR 25.8
(-0.77%)
EUR 25.8
(-0.77%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -18.94 Thousand EUR | -114.2% |
| 2022 | 133.43 Thousand EUR | 33.17% |
| 2021 | 100.2 Thousand EUR | 107.34% |
| 2020 | 48.32 Thousand EUR | -48.8% |
| 2019 | 94.38 Thousand EUR | 24288.11% |
| 2018 | 387.00 EUR | 100.01% |
| 2017 | -3.51 Million EUR | -351000100.0% |
| 2016 | 1.00 EUR | -100.0% |
| 2015 | 217 Thousand EUR | 21699900.0% |
| 2014 | 1.00 EUR | -100.0% |
| 2013 | 1.28 Million EUR | 612.15% |
| 2012 | 181 Thousand EUR | -29.57% |
| 2011 | 257 Thousand EUR | 198.84% |
| 2010 | 86 Thousand EUR | -33.85% |
| 2009 | 130 Thousand EUR | -15.58% |
| 2008 | 154 Thousand EUR | 1825.0% |
| 2007 | 8000.00 EUR | -73.33% |
| 2006 | 30 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - EUR | 100.0% |
| 2024 Q2 | 1.00 EUR | 0.0% |
| 2023 Q3 | 1.00 EUR | -100.0% |
| 2023 Q4 | -18.94 Thousand EUR | -1894984.0% |
| 2023 Q1 | 1.00 EUR | -100.0% |
| 2023 Q2 | 158.28 Thousand EUR | 15828000.0% |
| 2023 FY | -18.94 Thousand EUR | -114.2% |
| 2022 FY | 133.43 Thousand EUR | 33.17% |
| 2022 Q1 | 1.00 EUR | -100.0% |
| 2022 Q2 | 1.00 EUR | 0.0% |
| 2022 Q3 | 1.00 EUR | 0.0% |
| 2022 Q4 | 133.43 Thousand EUR | 13343800.0% |
| 2021 Q1 | 1.00 EUR | 0.0% |
| 2021 Q2 | 1.00 EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 100.2 Thousand EUR | 0.0% |
| 2021 FY | 100.2 Thousand EUR | 107.34% |
| 2020 Q3 | 1.00 EUR | 0.0% |
| 2020 FY | 48.32 Thousand EUR | -48.8% |
| 2020 Q1 | 1.00 EUR | -100.0% |
| 2020 Q2 | 1.00 EUR | 0.0% |
| 2020 Q4 | 1.00 EUR | 0.0% |
| 2019 FY | 94.38 Thousand EUR | 24288.11% |
| 2019 Q4 | 2 Million EUR | -56.85% |
| 2019 Q3 | 4.65 Million EUR | 38.02% |
| 2019 Q2 | 3.37 Million EUR | 337199900.0% |
| 2019 Q1 | 1.00 EUR | -100.0% |
| 2018 Q2 | 15.75 Million EUR | 787549900.0% |
| 2018 Q1 | 2.00 EUR | 0.0% |
| 2018 FY | 387.00 EUR | 100.01% |
| 2018 Q3 | 18.68 Million EUR | 18.62% |
| 2018 Q4 | 104.77 Thousand EUR | -99.44% |
| 2017 FY | -3.51 Million EUR | -351000100.0% |
| 2017 Q4 | - EUR | -100.0% |
| 2017 Q3 | 252 Thousand EUR | 54.6% |
| 2017 Q2 | 163 Thousand EUR | 30.4% |
| 2017 Q1 | 125 Thousand EUR | 12499900.0% |
| 2016 Q2 | 1.00 EUR | -100.0% |
| 2016 Q4 | 1.00 EUR | 0.0% |
| 2016 FY | 1.00 EUR | -100.0% |
| 2016 Q1 | 217 Thousand EUR | 21699900.0% |
| 2016 Q3 | - EUR | -100.0% |
| 2015 Q1 | 1.00 EUR | 0.0% |
| 2015 Q3 | 1.00 EUR | -100.0% |
| 2015 FY | 217 Thousand EUR | 21699900.0% |
| 2015 Q4 | 1.00 EUR | 0.0% |
| 2015 Q2 | 100 Thousand EUR | 9999900.0% |
| 2014 Q4 | 1.00 EUR | 0.0% |
| 2014 FY | 1.00 EUR | -100.0% |
| 2014 Q3 | 1.00 EUR | 0.0% |
| 2014 Q2 | 1.00 EUR | -100.0% |
| 2014 Q1 | 1.28 Million EUR | 2161.4% |
| 2013 Q3 | 2000.00 EUR | -98.66% |
| 2013 Q4 | 57 Thousand EUR | 2750.0% |
| 2013 FY | 1.28 Million EUR | 612.15% |
| 2013 Q1 | 181 Thousand EUR | -10.4% |
| 2013 Q2 | 149 Thousand EUR | -17.68% |
| 2012 Q1 | 257 Thousand EUR | 55.76% |
| 2012 Q3 | 204 Thousand EUR | -7.69% |
| 2012 Q4 | 202 Thousand EUR | -0.98% |
| 2012 FY | 181 Thousand EUR | -29.57% |
| 2012 Q2 | 221 Thousand EUR | -14.01% |
| 2011 FY | 257 Thousand EUR | 198.84% |
| 2011 Q2 | 97 Thousand EUR | 12.79% |
| 2011 Q1 | 86 Thousand EUR | -55.21% |
| 2011 Q3 | 116 Thousand EUR | 19.59% |
| 2011 Q4 | 165 Thousand EUR | 42.24% |
| 2010 Q2 | 114 Thousand EUR | -12.31% |
| 2010 FY | 86 Thousand EUR | -33.85% |
| 2010 Q1 | 130 Thousand EUR | 0.0% |
| 2010 Q4 | 192 Thousand EUR | 638.46% |
| 2010 Q3 | 26 Thousand EUR | -77.19% |
| 2009 FY | 130 Thousand EUR | -15.58% |
| 2009 Q3 | 159 Thousand EUR | 0.0% |
| 2008 FY | 154 Thousand EUR | 1825.0% |
| 2007 FY | 8000.00 EUR | -73.33% |
| 2006 FY | 30 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| DocCheck AG | 3.21 Million EUR | 100.59% |
| CompuGroup Medical SE & Co. KGaA | 18.88 Million EUR | 100.1% |
| Nexus AG | 3.22 Million EUR | 100.587% |